Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 01:51:18 UTC |
---|
Update Date | 2021-09-26 22:58:49 UTC |
---|
HMDB ID | HMDB0248505 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Apatinib |
---|
Description | Apatinib, also known as apatinib mesylate or rivoceranib, belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group. Based on a literature review a significant number of articles have been published on Apatinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Apatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Apatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C1 InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30) |
---|
Synonyms | Value | Source |
---|
Apatinib mesylate | HMDB | Rivoceranib | HMDB | Rivoceranib mesylate | HMDB |
|
---|
Chemical Formula | C24H23N5O |
---|
Average Molecular Weight | 397.482 |
---|
Monoisotopic Molecular Weight | 397.190260381 |
---|
IUPAC Name | N-[4-(1-cyanocyclopentyl)phenyl]-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide |
---|
Traditional Name | N-[4-(1-cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=C(NCC2=CC=NC=C2)N=CC=C1 |
---|
InChI Identifier | InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30) |
---|
InChI Key | WPEWQEMJFLWMLV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Anilides |
---|
Direct Parent | Aromatic anilides |
---|
Alternative Parents | |
---|
Substituents | - Aromatic anilide
- Nicotinamide
- Pyridinecarboxamide
- Pyridine carboxylic acid or derivatives
- Aminopyridine
- Pyridine
- Imidolactam
- Heteroaromatic compound
- Vinylogous amide
- Secondary carboxylic acid amide
- Carboxamide group
- Nitrile
- Carbonitrile
- Carboxylic acid derivative
- Organoheterocyclic compound
- Azacycle
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organic oxide
- Cyanide
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Apatinib,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 3558.4 | Semi standard non polar | 33892256 | Apatinib,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 3406.4 | Standard non polar | 33892256 | Apatinib,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 4824.3 | Standard polar | 33892256 | Apatinib,1TMS,isomer #2 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 3535.9 | Semi standard non polar | 33892256 | Apatinib,1TMS,isomer #2 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 3485.8 | Standard non polar | 33892256 | Apatinib,1TMS,isomer #2 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 4764.2 | Standard polar | 33892256 | Apatinib,2TMS,isomer #1 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C | 3392.1 | Semi standard non polar | 33892256 | Apatinib,2TMS,isomer #1 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C | 3335.1 | Standard non polar | 33892256 | Apatinib,2TMS,isomer #1 | C[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C | 4502.4 | Standard polar | 33892256 | Apatinib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 3815.4 | Semi standard non polar | 33892256 | Apatinib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 3604.2 | Standard non polar | 33892256 | Apatinib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CN=C1NCC1=CC=NC=C1)C1=CC=C(C2(C#N)CCCC2)C=C1 | 4884.7 | Standard polar | 33892256 | Apatinib,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 3790.0 | Semi standard non polar | 33892256 | Apatinib,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 3684.6 | Standard non polar | 33892256 | Apatinib,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)NC1=CC=C(C2(C#N)CCCC2)C=C1 | 4834.0 | Standard polar | 33892256 | Apatinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C | 3804.2 | Semi standard non polar | 33892256 | Apatinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C | 3742.2 | Standard non polar | 33892256 | Apatinib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1=CC=NC=C1)C1=NC=CC=C1C(=O)N(C1=CC=C(C2(C#N)CCCC2)C=C1)[Si](C)(C)C(C)(C)C | 4598.9 | Standard polar | 33892256 |
|
---|